RVL Pharmaceuticals (OSMT)
NASDAQ: OSMT
· Real-Time Price · USD
1.11
-0.02 (-1.77%)
At close: Jan 19, 2022, 5:00 AM
RVL Pharmaceuticals Revenue
RVL Pharmaceuticals reported an annual revenue of $49.72M, reflecting a 184.1% growth. For the quarter ending June 30, 2023, RVL Pharmaceuticals generated $8.26M in revenue.
Revenue (ttm)
$49.72M
Revenue Growth
184.1%
Price / Sales Ratio
2.02
Revenue / Employee
$164.64K
Employees
302
Market Cap
110.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|